Medlive Technology Co., Ltd.

2192

KYG5961B1041

Advertising & Marketing

Market Closed - Hong Kong S.E. Other stock markets 04:09:13 2024-04-23 am EDT			5-day change	1st Jan Change
7.87 ^HKD	+5.64%		+2.47%	-7.19%

Mar. 25	Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024	CI
Mar. 25	Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medlive Technology Co., Ltd.(SEHK:2192) added to S&P Global BMI Index

December 20, 2021 at 12:00 am EST

Latest news about Medlive Technology Co., Ltd.

Medlive Technology Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023, Payable on June 24, 2024	Mar. 25	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Medlive Technology to Double Profit in 2023	Feb. 28	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Year Ended 31 December 2023	Feb. 28	CI
Medlive to Buy 60% of Chinese Pharma Consulting Firm for Some 34 Million Yuan	23-10-13	MT
Medlive Technology’s Profit Soars 266% in H1	23-08-30	MT
Medlive Technology Co., Ltd. Announces Interim Dividend for the Six Months Ended 30 June 2023, Payable on 04 December 2023	23-08-29	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-29	CI
Medlive Technology to More than Triple H1 Profit	23-08-03	MT
Medlive Technology Co., Ltd. Provides Earnings Guidance for the Six Months Ended 30 June 2023	23-08-03	CI
Medlive Technology Unit to Buy 50% Stake in Beijing SCMedcon	23-06-13	MT
Medlive Technology Co., Ltd. Announces Executive Changes	23-06-12	CI
Medlive Technology Co., Ltd. Announces Director Changes	23-04-14	CI
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2022, Payable on July 10, 2023	23-03-23	CI
Medlive Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Medlive Technology's Profit to Rise in 2022	23-03-02	MT
Medlive Technology Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022	23-03-02	CI
M3's Fiscal Nine-month Attributable Profit Drops 30% on Increased Operating Costs	23-02-06	MT
Medlive Technology Sees No Explanation For Unusual Share Price Movement	22-12-13	MT
M3's Fiscal H1 Attributable Profit Plunges 41% on High-base Effect	22-11-03	MT
Medlive Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
M3's Fiscal Q1 Attributable Profit Tumbles 23% on High-base Effect; Shares Rise 13%	22-07-28	MT
Certain Ordinary Shares of Medlive Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 14-JUL-2022.	22-07-13	CI
Medlive Technology Buys 60% of Beijing Focus Innovation for $7.2 Million	22-06-08	MT
Medlive Technology Co., Ltd. Proposes Final Cash Dividend for the Year Ended December 31, 2021, Payable on July 11, 2022	22-03-24	CI

Chart Medlive Technology Co., Ltd.

Duration

Period

More charts

Medlive Technology Co Ltd is a China-based investment holding company mainly operates online professional physician platform. The Company mainly operates three segments. Its Precision Marketing and Corporate Solutions segment provides precision marketing solutions and corporate solutions. Its precision marketing solutions include digital detailing, digital marketing consulting and digital content creation services. Its revenue of its corporate solutions is primarily software as a service (SaaS). The Medical Knowledge Solutions segment mainly provides professional medical information and medical software services. The Intelligent Patient Management Solutions segment mainly provides online patient consultation and prescription services and patient management services. The Company mainly conducts its business within domestic market.

Sector

Advertising & Marketing

Calendar

2024-08-21 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Medlive Technology Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

7.275 CNY

Average target price

9.314 CNY

Spread / Average Target

+28.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advertising & Marketing

	1st Jan change	Capi.
MEDLIVE TECHNOLOGY CO., LTD.	-7.19%	691M
PUBLICIS GROUPE SA	+24.35%	27.13B
OMNICOM GROUP., INC.	+9.28%	18.36B
FOCUS MEDIA INFORMATION TECHNOLOGY CO., LTD.	+9.18%	13.92B
THE INTERPUBLIC GROUP OF COMPANIES, INC.	-4.58%	11.71B
WPP PLC	+5.79%	10.44B
JCDECAUX SE	+7.91%	4.38B
PEOPLE.CN CO., LTD	-12.79%	3.66B
HAKUHODO DY HOLDINGS INC	+34.98%	3.43B
CYBERAGENT, INC.	+15.41%	3.38B

Other Advertising & Marketing